Alkermes To Spin Out Oncology Business, Says Inflation Reduction Act Boosts Its Value

Company Raised CNS Product Revenue Guidance

 
• By Mandy Jackson
chain with arrows splits into two
The oncology business will split off from Alkermes in H2 2023 • Source: Shutterstock

More from Strategy

More from Business